muscular dystrophy Related Content
New public buildings to have Changing Places toilets for disabled people
New, or majorly refurbished, large buildings used by the public must have Changing Places toilets for severely disabled people, under government proposals.
Duchenne muscular dystrophy: A test case for gene-targeted therapy development in rare disease
Laura Hagerty, PhD, Scientific Portfolio Director at the Muscular Dystrophy Association, highlights strategies for gene correction to treat Duchenne muscular dystrophy.
Muscle wasting conditions: Transforming lives through research
Catherine Woodhead, CEO, Muscular Dystrophy UK explains how lives are being transformed through research when it comes to muscle wasting conditions.
The priorities for supporting people with muscle-wasting conditions
Some of the priorities for supporting people with muscle-wasting conditions and their families are explored here by Open Access Government
Duchenne muscular dystrophy (DMD): Correcting the dystrophin gene
Dr Ahlke Heydemann, Associate Professor and Director of Medical School Curriculum at University of Illinois, Chicago explains Duchenne muscular dystrophy (DMD), focussing on the issue of correcting the dystrophin gene
Muscular Dystrophy UK partnership to improve journeys for disabled road users
A new partnership with charity Muscular Dystrophy UK (MDUK) will bring Changing Places accessible toilets to the majority of motorway service areas — making journeys easier for disabled road users across England
All about the adult long-tailed knifefish S. macrurus
Graciela A. Unguez and Chiann-Ling C. Yeh from New Mexico State University explain that sarcomere disassembly is a naturally occurring event during tail regeneration in the adult long-tailed knifefish S. macrurus.
Advances in newborn screening for neuromuscular disease
Kristin Stephenson, Sr. VP, Chief Policy & Community Engagement Officer at the Muscular Dystrophy Association details the advances taking place in newborn screening for neuromuscular disease
Boris Šustaršič
Boris Šustaršič is the president of the European Alliance of Neuromuscular Disorders Associations (EAMDA).
The key issues around muscular dystrophy (MD) in Europe
Boris Šustaršič, President of the European Alliance of Neuromuscular Disorders Associations shares his thoughts on the key issues around muscular dystrophy (MD) in Europe today
